Siddharth M. Patel, MD, MPH

Siddharth M. Patel, MD, MPH, Brigham and Women's Hospital

Articles by Siddharth M. Patel, MD, MPH

Abelacimab Demonstrates Safety and Efficacy for Patients With AFib of All Ages: Sid Patel, MD

April 24th 2025

The continued success of abelacimab throughout the AZALEA-TIMI 71 trials helps draw the drug closer to FDA approval, stated Sid Patel, MD.

High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment

ByGiuliana Grossi,Christian Ruff, MD,John Buse, MD, PhD,Marc P. Bonaca, MD, MPH,Marc Humbert, MD, PhD,Jawad Haider Butt, MD, PhD,Siddharth M. Patel, MD, MPH

April 4th 2025

Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.

Siddharth M. Patel, MD, MPH

Articles by Siddharth M. Patel, MD, MPH

Abelacimab Demonstrates Safety and Efficacy for Patients With AFib of All Ages: Sid Patel, MD

High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment

Latest Updated Articles

Trending on AJMC

MRD-Guided CLL Treatment Duration: Personalization or Malpractice?

Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD

5 FAQs: Ebola Outbreaks and the Challenge of Public Trust

Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered

Blinatumomab Improves Outcomes, Toxicity in High-Risk Pediatric ALL: Martin Schrappe, MD, PhD